Outset Medical, Inc. (OM) Gross Margin
- Gross margin · 12 months: Value 41.76%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 41.76% | Gross profit / revenue. Period ending 2026-06-30. $49.20M ÷ $117.80M × 100 ≈ 41.76% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 49.20M USD | Gross Profit |
| Revenue | 117.80M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 68.61M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $49.20M | $117.80M | $68.61M | 41.76% |
| 2026-03-31 | $47.78M | $117.59M | $69.80M | 40.64% |
| 2025-12-31 | $46.75M | $119.48M | $72.72M | 39.13% |
| 2025-09-30 | $45.27M | $120.07M | $74.80M | 37.70% |
| 2025-06-30 | $43.50M | $119.30M | $75.80M | 36.46% |
| 2025-03-31 | $41.41M | $115.27M | $73.86M | 35.93% |
| 2024-12-31 | $38.56M | $113.69M | $75.13M | 33.92% |
| 2024-09-30 | $35.53M | $114.73M | $79.20M | 30.97% |
| 2024-06-30 | $32.87M | $116.42M | $83.56M | 28.23% |
| 2024-03-31 | $30.79M | $125.08M | $94.29M | 24.61% |
| 2023-12-31 | $29.00M | $130.38M | $101.38M | 22.24% |
| 2023-09-30 | $26.56M | $131.88M | $105.31M | 20.14% |
| 2023-06-30 | $23.74M | $129.28M | $105.53M | 18.36% |
| 2023-03-31 | $19.82M | $118.29M | $98.47M | 16.75% |
| 2022-12-31 | $17.83M | $115.38M | $97.54M | 15.46% |
| 2022-09-30 | $15.88M | $111.52M | $95.64M | 14.24% |
| 2022-06-30 | $14.49M | $110.08M | $95.59M | 13.16% |
| 2022-03-31 | $11.76M | $110.24M | $98.47M | 10.67% |
| 2021-12-31 | $7.61M | $102.60M | $94.99M | 7.42% |
| 2021-09-30 | $4.70M | $91.70M | $86.99M | 5.13% |
| 2021-06-30 | $-3.37M | $79.14M | $82.50M | -4.26% |
| 2021-03-31 | $-9.18M | $65.66M | $74.84M | -13.99% |
| 2020-12-31 | $-13.04M | $49.94M | $62.97M | -26.11% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | $-16.40M | $28.65M | (m) | -57.26% |
| 2020-03-31 | $-16.11M | $19.78M | (m) | -81.45% |
| 2019-12-31 | $-17.80M | $15.08M | $32.88M | -118.07% |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-6.12M | $2.01M | $8.12M | -304.68% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |